MedPage Today -- Adding the long-acting anticholinergic tiotropium (Spiriva) to a low-dose inhaled glucocorticoid resulted in better asthma control than doubling the dose of the glucocorticoid, a double-blind, three-way trial found.
MedPage Today -- Adding the long-acting anticholinergic tiotropium (Spiriva) to a low-dose inhaled glucocorticoid resulted in better asthma control than doubling the dose of the glucocorticoid, a double-blind, three-way trial found.